PATTERNS AND FACTORS ASSOCIATED WITH LOW ADHERENCE TO PSYCHOTROPIC MEDICATIONS DURING PREGNANCY-A CROSS-SECTIONAL, MULTINATIONAL WEB-BASED STUDY
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
BACKGROUND: No previous studies have explored how closely women follow their psychotropic drug regimens during pregnancy. This study aimed to explore patterns of and factors associated with low adherence to psychotropic medication during pregnancy. METHODS: Multinational web-based study was performed in 18 countries in Europe, North America, and Australia. Uniform data collection was ensured via an electronic questionnaire. Pregnant women were eligible to participate. Adherence was measured via the 8-item Morisky Medication Adherence Scale (MMAS-8). The Beliefs about Prescribed Medicines Questionnaire (BMQ-specific), the Edinburgh Postnatal Depression Scale (EPDS), and a numeric rating scale were utilized to measure women's beliefs, depressive symptoms, and antidepressant risk perception, respectively. Participants reporting use of psychotropic medication during pregnancy (n = 160) were included in the analysis. RESULTS: On the basis of the MMAS-8, 78 of 160 women (48.8%, 95% CI: 41.1-56.4%) demonstrated low adherence during pregnancy. The rates of low adherence were 51.3% for medication for anxiety, 47.2% for depression, and 42.9% for other psychiatric disorders. Smoking during pregnancy, elevated antidepressant risk perception (risk≥6), and depressive symptoms were associated with a significant 3.9-, 2.3-, and 2.5-fold increased likelihood of low medication adherence, respectively. Women on psychotropic polytherapy were less likely to demonstrate low adherence. The belief that the benefit of pharmacotherapy outweighed the risks positively correlated (r = .282) with higher medication adherence. CONCLUSIONS: Approximately one of two pregnant women using psychotropic medication demonstrated low adherence in pregnancy. Life-style factors, risk perception, depressive symptoms, and individual beliefs are important factors related to adherence to psychotropic medication in pregnancy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Retracted: Predictive Validity of a Medication Adherence Measure in an Outpatient Setting
Morisky, D. E., Ang, A., Krousel‐Wood, M., & Ward, H. J. (2008) · The Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2008.07572.x · Cited by 2,877 · cited 4×
“For each disorder-specific MMAS-8, the sum score (range 0–8) was calculated and then trichotomized into low (sum score < 6), medium (sum score 6 or 7), and high (sum score = 8) adherence.[21] Imputed values were generated when respondents completed at least six of the eight items on the MMAS-8 ( 75% completion), using…”
BackgroundMethodInfluentialRetractedPerinatal Depression: A Systematic Review of Prevalence and Incidence
Gavin, N. I., Gaynes, B. N., Lohr, K. N., Meltzer-Brody, S., Gartlehner, G., & Swinson, T. (2005) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000183597.31630.db · Cited by 3,282
Horne, R., & Weinman, J. (1999) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(99)00057-4 · Cited by 2,201 · cited 1×
“Women’s beliefs about medicines were explored via the Beliefs about Prescribed Medicines Questionnaire (BMQ-specific) that comprises two subscales: the BMQ-Necessity (five items) and BMQ-Concerns (five items).[31, 32] Respondents indicated their degree of agreement with each statement on a 5-point Likert scale (1 = st…”
MethodGrote, N. K., Bridge, J. A., Gavin, A. R., Melville, J. L., Iyengar, S., & Katon, W. J. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.111 · Cited by 1,882 · cited 2×
“[16, 17] Since medication discontinuation or suboptimal drug therapy of the underlying psychiatric disorder may lead to a relapse of the disorder over the course of the pregnancy and to adverse pregnancy outcomes,[10, 11, 18] more insight into the extent of and risk factors for low adherence during pregnancy is warran…”
BackgroundGeneralized Estimating Equations
Hardin, J. W., & Hilbe, J. M. (2002) · doi:10.1201/9781420035285 · Cited by 1,766
Prevalence of Depression During Pregnancy: Systematic Review
Bennett, H. A., Einarson, A., Taddio, A., Koren, G., & Einarson, T. R. (2004) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000116689.75396.5f · Cited by 1,725 · cited 1×
“5% of women, respectively.[2, 4, 5] Psychiatric disorders frequently require pharmacological treatment, even in pregnancy.”
BackgroundHorne, R., Chapman, S. C. E., Parham, R., Freemantle, N., Forbes, A., & Cooper, V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080633 · Cited by 1,174
Cohen, L. S. (2006) · JAMA · doi:10.1001/jama.295.5.499 · Cited by 1,031
Alder, J., Fink, N., Bitzer, J., Hösli, I., & Holzgreve, W. (2007) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767050701209560 · Cited by 872 · cited 1×
“[16, 17] Since medication discontinuation or suboptimal drug therapy of the underlying psychiatric disorder may lead to a relapse of the disorder over the course of the pregnancy and to adverse pregnancy outcomes,[10, 11, 18] more insight into the extent of and risk factors for low adherence during pregnancy is warran…”
BackgroundGrigoriadis, S., VonderPorten, E. H., Mamisashvili, L., Tomlinson, G., Dennis, C.-L., Koren, G., Steiner, M., Mousmanis, P., Cheung, A., Radford, K., et al. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12r07968 · Cited by 797
Use of antidepressant medications during pregnancy: a multisite study
Andrade, S. E., Raebel, M. A., Brown, J., Lane, K., Livingston, J., Boudreau, D., Rolnick, S. J., Roblin, D., Smith, D. H., Willy, M. E., et al. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.07.036 · Cited by 403
Petersen, I., Gilbert, R. E., Evans, S. J. W., Man, S.-L., & Nazareth, I. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10m06090blu · Cited by 192 · cited 1×
“[13, 14] Pregnancy has been described to be the driving factor for discontinuation of antidepressant therapy,[15] nevertheless, no previous studies have explored how closely pregnant women follow their psychotropic regimens in the context of ongoing use.”
BackgroundBakker, M. K., Kölling, P., Van Den Berg, P. B., De Walle, H. E. K., & De Jong van den Berg, L. T. W. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.03048.x · Cited by 158
Maternal postnatal depression and child growth: a European cohort study
Grote, V., Vik, T., von Kries, R., Luque, V., Socha, J., Verduci, E., Carlier, C., Koletzko, B., & the European Childhood Obesity Trial Study Group (2010) · BMC Pediatrics · doi:10.1186/1471-2431-10-14 · Cited by 92 · cited 1×
“[27–30]”
Adherence to continuation and maintenance antidepressant use in recurrent depression
ten Doesschate, M. C., Bockting, C. L. H., & Schene, A. H. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.07.011 · Cited by 86 · cited 1×
“The results are however in line with prevalence estimates of nonadherence in the general nonpregnant population with psychiatric disorders (40–53%),[42, 43] but higher than what we previously found among women with somatic illness during pregnancy, using”
Result
Cited by
Ailes, E. C., Simeone, R. M., Dawson, A. L., Petersen, E. E., & Gilboa, S. M. (2016) · Birth Defects Research Part A: Clinical and Molecular Teratology · doi:10.1002/bdra.23573 · Cited by 112
“Previous estimates of antidepressant adherence during pregnancy are conflicting; the proportion of pregnant women estimated to have low adherence ranges from 13 to 47% (Bosman et al., 2014; Lupattelli et al., 2015).”
BackgroundInsomnia Treatment Preferences During Pregnancy
Sedov, I. D., Goodman, S. H., & Tomfohr-Madsen, L. M. (2017) · Journal of Obstetric, Gynecologic & Neonatal Nursing · doi:10.1016/j.jogn.2017.01.005 · Cited by 66
Molenaar, N. M., Lambregtse-van den Berg, M. P., & Bonsel, G. J. (2020) · Archives of Women's Mental Health · doi:10.1007/s00737-019-0951-5 · Cited by 30
Tunnell, N. C., Suterwala, M., & Meuret, A. E. (2019) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2019.10.004 · Cited by 9
Lupattelli, A., Branquinho, M., Cardoso, C., Tauqeer, F., Bjørndal, L. D., & Fonseca, A. (2024) · Patient Education and Counseling · doi:10.1016/j.pec.2024.108337 · Cited by 1
Self-citation
Metadata
- Authors
- Lupattelli, A., Spigset, O., Björnsdóttir, I., Hämeen-Anttila, K., Mårdby, A.-C., Panchaud, A., Juraski, R. G., Rudolf, G., Odalovic, M., Drozd, M., Twigg, M. J., Juch, H., Moretti, M. E., Kennedy, D., Rieutord, A., Zagorodnikova, K., Passier, A., & Nordeng, H.
- Venue
- Depression and Anxiety
- Publisher
- Wiley
- Published
- 2015-02-20
- Volume
- 32
- Issue
- 6
- Pages
- 426-436
- ISSN
- 1091-4269 (ISSN-L)
- OpenAlex
- W1542196529
- Cited by
- 62
- References
- 15
- FWCI
- 9.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.